Recently, Ginkgo Bioworks announced the acquisition of DNA synthesis provider Gen9 for an undisclosed amount of cash and stock. Ginkgo will integrate into its existing Bioworks facilities Gen9's BioFab platform, which includes...
Contact us to learn the benefits of becoming a Lux member.
Or call us now
For North America (Boston Headquarters)
+1 (617) 502-5300
For EMEA (Amsterdam)
+31 20 280 7900
For APAC (Singapore)